-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
- Verrica Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 46.5M shares, a 1.28% increase year-over-year.
- Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 45.3M shares, a 32.7% increase from 2022.
- Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 34.2M shares, a 26.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)